CD274 and breast adenocarcinoma: Because a similar portion (1/5, 20%) of mammary adenocarcinoma tissues was PD-L1-negative in our IHC results, investigation of the frequency and types of, for example, genetic mutations in mammary adenocarcinoma may provide further insights into the regulatory mechanisms of PD-L1 in feline tumors.